IGM Biosciences, Inc.
IGM Biosciences, Inc.（IGMS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
igms · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2025年10月31日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Hold
18 位分析师
共识
评级分布
12 个月目标价
High
$31.00
Consensus
$16.79
+1222.0% upside
Low
$1.50
Median: $21 · Last Close: $1.27
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.27 | ↑ 0.10% |
1-day model range: $1.26–$1.28. Peak: $1.28 (+0.10%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · IGMS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-06-11 | Truist Securities | Maintains | Hold→Hold |
| 2025-01-13 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2025-01-10 | Stifel | Downgrade ↓ | Buy→Hold |
| 2025-01-10 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-01-10 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-01-10 | Truist Securities | Maintains | Hold→Hold |
| 2025-01-10 | BMO Capital | Downgrade ↓ | Outperform→Market Perform |
| 2024-11-11 | Stifel | Maintains | Buy→Buy |
| 2024-10-18 | RBC Capital | Maintains | Outperform→Outperform |
| 2024-10-01 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
Wall Street analysts have recently issued updated ratings on IGM Biosciences, Inc. (IGMS) stock. Of the recent 82 rating actions, 3 were upgrades and 12 were downgrades. 18 analysts currently cover IGMS.
分析师推荐趋势
IGMS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$9M
↓ 33.7% YoY
Revenue Next Year
$14M
↑ 46.6% YoY
EPS This Year
$-1.65
EPS Next Year
$-1.40
↓ 15.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast IGMS EPS of $-1.65 for the current fiscal year, based on estimates from 2 analysts. The IGMS revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IGMS 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IGMS 的共识目标价为 $16.79（+1222.0% 上行空间），分析师共识为 Hold。
IGMS 的短期预测（明日）为 $1.27（+0.10%）。
IGM Biosciences, Inc. 在 NASDAQ 上市，代码 IGMS。IGMS 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 44% 对应 Hold 共识。
常见问题
IGMS 预测 · 8 个问题根据 18 位华尔街分析师，IGMS 的 12 个月平均目标价为 $16.79，最高 $31.00、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $1.27，隐含约 +1222.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.